Cite
HARVARD Citation
Ananworanich, J. et al. (2022). Randomized Study of Rivaroxaban vs Placebo on Disease Progression and Symptoms Resolution in High-Risk Adults With Mild Coronavirus Disease 2019. Clinical infectious diseases. pp. e473-e481. [Online].